Education
About Us
Working with TipRanks
Follow Us
Medicine Man Technologies (SHWZ)
OTHER OTC:SHWZ
RESEARCH TOOLSreports
Total Valuation
Medicine Man Technologies has a market cap or net worth of $430.37K. The enterprise value is ―.
Market Cap$430.37K
Enterprise Value―
Share Statistics
Medicine Man Technologies has 78,248,390 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding78,248,390
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medicine Man Technologies’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is 2.47%.
Return on Equity (ROE)-0.29
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)2.47%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee236.55K
Profits Per Employee-47.39K
Employee Count729
Asset Turnover0.48
Inventory Turnover3.74
Valuation Ratios
The current PE Ratio of Medicine Man Technologies is -1.14. Medicine Man Technologies’s PEG ratio is 0.05.
PE Ratio-1.14
PS Ratio0.00
PB Ratio0.33
Price to Fair Value0.33
Price to FCF24.82
Price to Operating Cash Flow3.22
PEG Ratio0.05
Income Statement
In the last 12 months, Medicine Man Technologies had revenue of 172.45M and earned -34.55M in profits. Earnings per share was -0.26.
Revenue172.45M
Gross Profit76.02M
Operating Income3.29M
Pretax Income-14.81M
Net Income-34.55M
EBITDA37.52M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was 6.59M and capital expenditures -8.06M, giving a free cash flow of -1.47M billion.
Operating Cash Flow6.59M
Free Cash Flow-1.47M
Free Cash Flow per Share-0.02
Dividends & Yields
Medicine Man Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1011.69
52-Week Price Change-98.53%
50-Day Moving Average0.02
200-Day Moving Average0.18
Relative Strength Index (RSI)44.83
Average Volume (3m)5.58K
Important Dates
Medicine Man Technologies upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Medicine Man Technologies as a current ratio of 0.97, with Debt / Equity ratio of 218.30%
Current Ratio0.97
Quick Ratio0.50
Debt to Market Cap3.99
Net Debt to EBITDA4.60
Interest Coverage Ratio0.10
Taxes
In the past 12 months, Medicine Man Technologies has paid 19.74M in taxes.
Income Tax19.74M
Effective Tax Rate-1.33
Enterprise Valuation
Medicine Man Technologies EV to EBITDA ratio is 5.65, with an EV/FCF ratio of 133.70.
EV to Sales1.23
EV to EBITDA5.65
EV to Free Cash Flow133.70
EV to Operating Cash Flow17.37
Balance Sheet
Medicine Man Technologies has $12.39M in cash and marketable securities with $75.84K in debt, giving a net cash position of $185.80M billion.
Cash & Marketable Securities$12.39M
Total Debt$75.84K
Net Cash$185.80M
Net Cash Per Share$2.37
Tangible Book Value Per Share-$1.77
Margins
Gross margin is 32.20%, with operating margin of 1.91%, and net profit margin of -20.03%.
Gross Margin32.20%
Operating Margin1.91%
Pretax Margin-8.59%
Net Profit Margin-20.03%
EBITDA Margin21.76%
EBIT Margin10.01%
Analyst Forecast
The average price target for Medicine Man Technologies is $4.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.00
Price Target Upside39900.00% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast5.55%
EPS Growth Forecast-32.90%